Epidural Injections for Pain Management
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Defines medical necessity criteria, prior authorization guidance, coding, and limitations for epidural steroid injections (cervical, thoracic, lumbar/caudal, transforaminal) for Commercial Products of BCBSRI. Excludes Medicare Advantage guidance and notes benefits may vary by contract.
No material clinical or coverage changes were made in this update.
Coverage Summary
Epidural injections (ESIs) are used for neck or back pain that has not responded to conservative measures; they deliver steroid or other therapeutic substances into the epidural space to reduce inflammation and relieve pressure on neural structures. This policy defines medical necessity criteria, prior authorization guidance, coding, and limits for ESIs (cervical, thoracic, lumbar/caudal, and transforaminal) for Commercial Products of BCBSRI. Medicare Advantage guidance is excluded and benefits may vary by group/contract.
Effective date: 03/01/2024. Policy last reviewed: 06/05/2024.
Medical Necessity Criteria
Coding
| 62320 | Interlaminar epidural or subarachnoid, cervical or thoracic; without imaging guidance |
| 62321 | Interlaminar epidural or subarachnoid, cervical or thoracic; with imaging guidance (ie, fluoroscopy or CT) |
| 62322 | Interlaminar epidural or subarachnoid, lumbar or sacral (caudal); without imaging guidance |
| 62323 | Interlaminar epidural or subarachnoid, lumbar or sacral (caudal); with imaging guidance (ie, fluoroscopy or CT) |
| 64479 | Transforaminal epidural, with imaging guidance (fluoroscopy or CT); cervical or thoracic, single level |
| 64483 | Transforaminal epidural, with imaging guidance (fluoroscopy or CT); lumbar or sacral, single level |
Provider Actions
Prior authorization recommended for Commercial Products
Prior authorization is recommended for Commercial Products and must be obtained via the online tool for participating providers. The listed CPT codes are affected. An approved authorization is valid for up to 4 epidural injections in a 12-month period from the requested date of service.
Authorization validity and limits
An approved authorization request is valid for up to 4 epidural injections in a 12-month period. If the member will exceed the initially approved number of injections, an additional authorization request is required. The policy recommends a period of no less than 90 days between injections.
- Minimum interval between injections: 90 days
Documentation of conservative therapy and imaging
Providers must document durations of conservative treatments when required by the criteria and must document imaging or testing evidence of nerve root compression when the radiculopathy criteria require it.
- NSAIDs or acetaminophen (durations per criteria: ≥ 3 weeks for non-specific LBP; ≥ 1 week or ≥ 3 weeks options for radiculopathy)
- Activity modification (durations per criteria: ≥ 6 weeks for non-specific LBP; ≥ 1 week or ≥ 6 weeks options for radiculopathy)
- Physical therapy (durations per criteria: ≥ 6 weeks for non-specific LBP; ≥ 1 week or ≥ 6 weeks options for radiculopathy)
- Imaging or testing evidence of nerve root compression when required by radiculopathy criteria
Exclusion conditions may render treatment not medically necessary
Claims may be denied if exclusionary conditions listed in the policy are present or if the medical criteria (including required conservative therapy durations and VAS thresholds) are not met.
- Local infection at injection site
- Increased intracranial pressure
- Epidural metastases
Background, Evidence & Definitions
Epidural steroid injections are intended for patients with neck or back pain refractory to conservative therapies; they may improve pain by reducing inflammation and relieving pressure on nerve roots or other pain-generating structures.
The evidence base for radiculopathy includes randomized trials and meta-analyses that show reduced pain in the short- to intermediate-term (up to 6 months), but no consistent long-term benefit. For nonspecific low back pain, most trials are low quality and the evidence is insufficient to demonstrate a net health benefit.
Techniques and study outcomes are heterogeneous (different approaches such as translaminar, transforaminal, caudal; with or without fluoroscopic guidance), which contributes to variability in results.
Serious adverse events are rare but have been reported; trials generally report mild adverse events but rates of serious events are not well defined.
| Evidence summary | Key point |
|---|---|
| Short- to intermediate-term benefit for radiculopathy | |
| Meta-analyses and RCTs show reduced pain up to 6 months; no long-term benefit demonstrated | |
| Evidence for nonspecific low back pain | |
| Most trials low quality with insufficient evidence of net health benefit |
| Term | Definition |
|---|---|
| Epidural injections (ESIs) | |
| Injection of steroid or other therapeutic substances into the epidural space via translaminar, transforaminal, or caudal approaches, with or without fluoroscopic guidance. | |
| Radiculopathy | |
| Irritation of one or more spinal nerve roots causing radiating pain, numbness, or weakness in a dermatomal distribution. |
Revision History
Policy effective date (policy published/effective).
Policy last reviewed (most recent review date).
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.